These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10817746)

  • 21. Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata.
    Miyazaki H; Miyazaki Y; Geber A; Parkinson T; Hitchcock C; Falconer DJ; Ward DJ; Marsden K; Bennett JE
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1695-701. PubMed ID: 9661006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumin potentiates the fungicidal effect of dodecanol by inhibiting drug efflux in wild-type budding yeast.
    Yamawaki C; Oyama M; Yamaguchi Y; Ogita A; Tanaka T; Fujita KI
    Lett Appl Microbiol; 2019 Jan; 68(1):17-23. PubMed ID: 30276838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Vesicular Transport Influences Fungal Susceptibility to Fluconazole.
    Demuyser L; Van Dyck K; Timmermans B; Van Dijck P
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The yeast multidrug resistance pump, Pdr5p, confers reduced drug resistance in erg mutants of Saccharomyces cerevisiae.
    Kaur R; Bachhawat AK
    Microbiology (Reading); 1999 Apr; 145 ( Pt 4)():809-818. PubMed ID: 10220160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic architecture of Hsp90-dependent drug resistance.
    Cowen LE; Carpenter AE; Matangkasombut O; Fink GR; Lindquist S
    Eukaryot Cell; 2006 Dec; 5(12):2184-8. PubMed ID: 17056742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism between two mechanisms of antifungal drug resistance.
    Anderson JB; Ricker N; Sirjusingh C
    Eukaryot Cell; 2006 Aug; 5(8):1243-51. PubMed ID: 16896209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cryptococcus neoformans Yap1 is required for normal fluconazole and oxidative stress resistance.
    Paul S; Doering TL; Moye-Rowley WS
    Fungal Genet Biol; 2015 Jan; 74():1-9. PubMed ID: 25445311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of gallic acid ester derivatives on Saccharomyces cerevisiae multidrug resistance protein Pdr5p.
    Pereira Rangel L; Fritzen M; Yunes RA; Leal PC; Creczynski-Pasa TB; Ferreira-Pereira A
    FEMS Yeast Res; 2010 May; 10(3):244-51. PubMed ID: 20132313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional isolation of the Candida albicans FCR3 gene encoding a bZip transcription factor homologous to Saccharomyces cerevisiae Yap3p.
    Yang X; Talibi D; Weber S; Poisson G; Raymond M
    Yeast; 2001 Sep; 18(13):1217-25. PubMed ID: 11561289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiae.
    Barker KS; Pearson MM; Rogers PD
    J Antimicrob Chemother; 2003 May; 51(5):1131-40. PubMed ID: 12697649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluconazole inhibits pseudohyphal growth in Saccharomyces cerevisiae.
    Kontoyiannis DP
    Chemotherapy; 2000; 46(2):100-3. PubMed ID: 10671759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole.
    Calabrese D; Bille J; Sanglard D
    Microbiology (Reading); 2000 Nov; 146 ( Pt 11)():2743-2754. PubMed ID: 11065353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Commercial systems for fluconazole susceptibility testing of yeasts: comparison with the broth microdilution method.
    Posteraro B; Romano L; Sanguinetti M; Masucci L; Morace G; Fadda G
    Diagn Microbiol Infect Dis; 2000 Sep; 38(1):29-36. PubMed ID: 11025181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro pharmacological study of fluconazole. Evaluation of an antifungal assay].
    Duval F; Lavarde V
    Pathol Biol (Paris); 1993 May; 41(5):469-73. PubMed ID: 8414680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluconazole toxicity is independent of oxidative stress and apoptotic effector mechanisms in Saccharomyces cerevisiae.
    Kontoyiannis DP; Murray PJ
    Mycoses; 2003 Jun; 46(5-6):183-6. PubMed ID: 12801359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digoxin Derivatives Sensitize a
    de Moraes DC; Tessis AC; Rollin-Pinheiro R; Princival JL; Villar JAFP; Barbosa LA; Barreto-Bergter E; Ferreira-Pereira A
    J Fungi (Basel); 2022 Jul; 8(8):. PubMed ID: 35893137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voriconazole and multidrug resistance in Candida albicans.
    Wakieć R; Prasad R; Morschhäuser J; Barchiesi F; Borowski E; Milewski S
    Mycoses; 2007 Mar; 50(2):109-15. PubMed ID: 17305773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters.
    Nakamura K; Niimi M; Niimi K; Holmes AR; Yates JE; Decottignies A; Monk BC; Goffeau A; Cannon RD
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3366-74. PubMed ID: 11709310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluconazole modulates membrane rigidity, heterogeneity, and water penetration into the plasma membrane in Saccharomyces cerevisiae.
    Abe F; Usui K; Hiraki T
    Biochemistry; 2009 Sep; 48(36):8494-504. PubMed ID: 19670905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans.
    Lo HJ; Tseng KY; Kao YY; Tsao MY; Lo HL; Yang YL
    Int J Antimicrob Agents; 2015 Jun; 45(6):617-21. PubMed ID: 25802233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.